Cell therapy field charts path forward on engineered cell particles

The International Society for Cell & Gene Therapy convened experts to assess therapeutic potential of extracellular vesicles—tiny cell-derived particles being developed as drug delivery vehicles and treatments. The findings could reshape how companies approach next-generation cell therapies and influence regulatory decisions on what counts as a viable treatment modality.

Originaltitel: A report on the International Society for Cell & Gene Therapy 2022 Scientific Signature Series, "Therapeutic advances with native and engineered human extracellular vesicles"